{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:27:21Z","timestamp":1792070841177,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jcyt.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T17:53:25Z","timestamp":1562954005000},"page":"911-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy"],"prefix":"10.1016","volume":"21","author":[{"given":"KAREN","family":"Bieback","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BEATRIZ","family":"FERNANDEZ-MU\u00d1OZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIBANI","family":"PATI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RICHARD","family":"SCH\u00c4FER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jcp.20391","article-title":"Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications","volume":"205","author":"Doucet","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-62703-128-8_22","article-title":"Generation of a pool of human platelet lysate and efficient use in cell culture","volume":"946","author":"Schallmoser","year":"2013","journal-title":"Methods in molecular biology"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0003","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/vox.12593","article-title":"International Forum on GMP-grade human platelet lysate for cell propagation: summary","volume":"113","author":"Strunk","year":"2018","journal-title":"Vox sanguinis"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0004","first-page":"e1","article-title":"International Forum on GMP-grade human platelet lysate for cell propagation","volume":"113","author":"Strunk","year":"2018","journal-title":"Vox sanguinis"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13287-016-0352-x","article-title":"Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem\/stromal cells: present and future","volume":"7","author":"Astori","year":"2016","journal-title":"Stem cell research & therapy"},{"issue":"5","key":"10.1016\/j.jcyt.2019.06.006_bib0006","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000354061","article-title":"Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures","volume":"40","author":"Bieback","year":"2013","journal-title":"Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0007","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbt.2014.06.001","article-title":"Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion","volume":"32","author":"Shih","year":"2015","journal-title":"New biotechnology"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0008","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/trf.15174","article-title":"Human platelet lysate current standards and future developments","volume":"59","author":"Henschler","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/10_2012_134","article-title":"Expansion of Mesenchymal Stem\/Stromal cells under xenogenic-free culture conditions","volume":"129","author":"Kinzebach","year":"2013","journal-title":"Advances in biochemical engineering\/biotechnology"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.tiv.2010.03.016","article-title":"Optimization of chemically defined cell culture media\u2013replacing fetal bovine serum in mammalian in vitro methods","volume":"24","author":"van der Valk","year":"2010","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcyt.2016.11.011","article-title":"A consensus introduction to serum replacements and serum-free media for cellular therapies","volume":"19","author":"Karnieli","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0012","unstructured":"International Serum Industry Organisation, FAQ- Bovine Serumhttps:\/\/www.serumindustry.org\/resources\/faq\/, Accessed 2 July 2019."},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0013","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/026119290203000208","article-title":"The use of fetal bovine serum: ethical or scientific problem?","volume":"30","author":"Jochems","year":"2002","journal-title":"Alternatives to laboratory animals: ATLA"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2003.08.009","article-title":"The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture","volume":"18","author":"van der Valk","year":"2004","journal-title":"Toxicology In Vitro: an international journal published in association with BIBRA"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.12665\/J123.Siegel","article-title":"Fetal Bovine Serum: The Impact of Geography","volume":"12","author":"Siegel","year":"2013","journal-title":"BioProcessing Journal"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0016","doi-asserted-by":"crossref","DOI":"10.12665\/J16OA.Cheever","article-title":"A method for differentiating fetal bovine serum from newborn calf serum","volume":"16","author":"Cheever","year":"2017","journal-title":"BioProcess J"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0017","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/hum.2011.2501","article-title":"Safety of bovine sera for production of mesenchymal stem cells for therapeutic use","volume":"22","author":"Reinhardt","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0018","unstructured":"European Pharmacopoeia (Ph. Eur.) 9th Edition. Strasbourg, France: Council of Europe; 2017."},{"key":"10.1016\/j.jcyt.2019.06.006_bib0019","unstructured":"EMA\/CHMP\/BWP\/457920\/2012 rev 1, Guideline on the use of bovine serum in the manufacture of human biological medicinal products. Accessed June 2019."},{"issue":"9","key":"10.1016\/j.jcyt.2019.06.006_bib0020","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3324\/haematol.11446","article-title":"No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients","volume":"92","author":"Sundin","year":"2007","journal-title":"Haematol-Hematol J"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0021","unstructured":"EMA\/410\/01 rev. 3, Note for Guidance on Minimising the Risk of Transmitting Animal Spongiform Encephalopathy Agents Via Human and Veterinary Medicinal Products."},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0022","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/art.1780230213","article-title":"Effect of platelet lysate on growth and sulfated glycosaminoglycan synthesis in articular chondrocyte cultures","volume":"23","author":"Choi","year":"1980","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"10.1016\/j.jcyt.2019.06.006_bib0023","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF02619199","article-title":"Human platelet lysate contains growth factor activities for established cell lines derived from various tissues of several species","volume":"16","author":"Eastment","year":"1980","journal-title":"In Vitro"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0024","first-page":"1212","article-title":"Platelets as a Source of Growth-Promoting Factor(S) for Tumor-Cells","volume":"40","author":"Hara","year":"1980","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.jcyt.2019.06.006_bib0025","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/S0142-9612(03)00114-5","article-title":"Platelet-derived growth factors enhance proliferation of human stromal stem cells","volume":"24","author":"Lucarelli","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0026","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13287-016-0352-x","article-title":"Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem\/stromal cells: present and future","volume":"7","author":"Astori","year":"2016","journal-title":"Stem cell research & therapy"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0027","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biomaterials.2015.10.065","article-title":"Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?","volume":"76","author":"Burnouf","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0028","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fbioe.2017.00066","article-title":"Culture Medium Supplements Derived from Human Platelet and Plasma: Cell Commitment and Proliferation Support","volume":"5","author":"Muraglia","year":"2017","journal-title":"Frontiers in bioengineering and biotechnology"},{"issue":"11","key":"10.1016\/j.jcyt.2019.06.006_bib0029","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","article-title":"Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2013current views","volume":"25","author":"Phinney","year":"2007","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise Review: MSC-Derived Exosomes for Cell-Free Therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0031","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/jor.21333","article-title":"Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non-cemented hip prosthesis integration","volume":"29","author":"Dozza","year":"2011","journal-title":"Journal of orthopaedic research: official publication of the Orthopaedic Research Society"},{"issue":"18","key":"10.1016\/j.jcyt.2019.06.006_bib0032","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.yexcr.2012.06.004","article-title":"Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells","volume":"318","author":"Lange","year":"2012","journal-title":"Experimental cell research"},{"issue":"11","key":"10.1016\/j.jcyt.2019.06.006_bib0033","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1002\/eji.201141542","article-title":"Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function","volume":"41","author":"Abdelrazik","year":"2011","journal-title":"European journal of immunology"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0034","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10875-011-9581-z","article-title":"Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate","volume":"31","author":"Flemming","year":"2011","journal-title":"Journal of clinical immunology"},{"issue":"9","key":"10.1016\/j.jcyt.2019.06.006_bib0035","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1537-2995.2009.02226.x","article-title":"Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy","volume":"49","author":"Perez-Ilzarbe","year":"2009","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.jcyt.2019.06.006_bib0036","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.jcyt.2019.06.006_bib0037","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.bbmt.2018.07.015","article-title":"Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation","volume":"24","author":"Trento","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0038","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/157488811797904371","article-title":"Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique","volume":"6","author":"Centeno","year":"2011","journal-title":"Current stem cell research & therapy"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0039","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2013.11.033","article-title":"Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients","volume":"20","author":"Introna","year":"2014","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/bmt.2008.316","article-title":"Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium","volume":"43","author":"von Bonin","year":"2009","journal-title":"Bone marrow transplantation"},{"issue":"32","key":"10.1016\/j.jcyt.2019.06.006_bib0041","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1016\/j.biomaterials.2013.06.050","article-title":"The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy","volume":"34","author":"Copland","year":"2013","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jcyt.2019.06.006_bib0042","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1634\/stemcells.2006-0627","article-title":"Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue","volume":"25","author":"Kocaoemer","year":"2007","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0043","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2121-14-48","article-title":"Functional and differential proteomic analyses to identify platelet derived factors affecting ex vivo expansion of mesenchymal stromal cells","volume":"14","author":"Kinzebach","year":"2013","journal-title":"BMC cell biology"},{"issue":"9","key":"10.1016\/j.jcyt.2019.06.006_bib0044","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/stem.139","article-title":"Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow","volume":"27","author":"Bieback","year":"2009","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"12","key":"10.1016\/j.jcyt.2019.06.006_bib0045","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1111\/j.1537-2995.2009.02346.x","article-title":"Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate","volume":"49","author":"Blande","year":"2009","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.jcyt.2019.06.006_bib0046","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1089\/scd.2012.0594","article-title":"Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls","volume":"22","author":"Menard","year":"2013","journal-title":"Stem cells and development"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0047","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/ten.tea.2008.0498","article-title":"Platelet Lysate as a Serum Substitute for 2D Static and 3D Perfusion Culture of Stromal Vascular Fraction Cells from Human Adipose Tissue","volume":"15","author":"Muller","year":"2009","journal-title":"Tissue Eng Pt A"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0048","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biomaterials.2015.10.065","article-title":"Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?","volume":"76","author":"Burnouf","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.jcyt.2019.06.006_bib0049","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1634\/stemcells.2007-0127","volume":"25","author":"Mannello","year":"2007","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0050","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00103-015-2238-y","article-title":"Spezifische Aspekte zur Virussicherheit von Produktionshilfsstoffen f\u00fcr somatische Zelltherapie-Arzneimittel","volume":"58","author":"St\u00fchler","year":"2015","journal-title":"Bundesgesundheitsbl"},{"issue":"7","key":"10.1016\/j.jcyt.2019.06.006_bib0051","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/14653249.2010.501788","article-title":"Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells","volume":"12","author":"Horn","year":"2010","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2019.06.006_bib0052","doi-asserted-by":"crossref","first-page":"e37839","DOI":"10.1371\/journal.pone.0037839","article-title":"Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells","volume":"7","author":"Lohmann","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0053","doi-asserted-by":"crossref","first-page":"6104780","DOI":"10.1155\/2016\/6104780","article-title":"Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke","volume":"2016","author":"Tan","year":"2016","journal-title":"Stem cells international"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0054","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbt.2014.06.001","article-title":"Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion","volume":"32","author":"Shih","year":"2015","journal-title":"New biotechnology"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0055","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1537-2995.2010.02915.x","article-title":"Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate","volume":"51","author":"Shih","year":"2011","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0056","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0973-6247.53882","article-title":"Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods","volume":"3","author":"Singh","year":"2009","journal-title":"Asian J Transfus Sci"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0057","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000371504","article-title":"Determining the Effect of Preparation and Storage: An Effort to Streamline Platelet Components as a Source of Growth Factors for Clinical Application","volume":"42","author":"Sonker","year":"2015","journal-title":"Transfus Med Hemoth"},{"issue":"5","key":"10.1016\/j.jcyt.2019.06.006_bib0058","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/14653249.2012.655420","volume":"14","author":"Fekete","year":"2012","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0059","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jss.2005.01.013","article-title":"Expired liquid preserved platelet releasates retain proliferative activity","volume":"126","author":"Chan","year":"2005","journal-title":"J Surg Res"},{"issue":"8","key":"10.1016\/j.jcyt.2019.06.006_bib0060","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3727\/096368914X683043","article-title":"Expired and Pathogen-Inactivated Platelet Concentrates Support Differentiation and Immunomodulation of Mesenchymal Stromal Cells in Culture","volume":"24","author":"Jonsdottir-Buch","year":"2015","journal-title":"Cell transplantation"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0061","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcyt.2016.10.014","article-title":"Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentrates","volume":"19","author":"Glovinski","year":"2017","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0062","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/09537104.2018.1445840","article-title":"Comparison of human platelet lysate alternatives using expired and freshly isolated platelet concentrates for adipose-derived stromal cell expansion","volume":"30","author":"Dessels","year":"2019","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0063","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10616-014-9841-x","article-title":"A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells","volume":"68","author":"Laitinen","year":"2016","journal-title":"Cytotechnology"},{"issue":"12","key":"10.1016\/j.jcyt.2019.06.006_bib0064","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jcyt.2013.06.014","article-title":"Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures","volume":"15","author":"Mojica-Henshaw","year":"2013","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0065","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0022-5223(03)00813-4","article-title":"Life-threatening anaphylactic shock caused by porcine heparin intravenous infusion during mitral valve repair","volume":"126","author":"Bottio","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0066","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00216-011-5590-2","article-title":"Species-specific identification of ruminant components contaminating industrial crude porcine heparin using real-time fluorescent qualitative and quantitative PCR","volume":"402","author":"Huang","year":"2012","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"10.1016\/j.jcyt.2019.06.006_bib0067","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0003-4975(90)90037-7","article-title":"Use of Bovine Lung Heparin to Obviate Anaphylactic Shock Caused by Porcine Gut Heparin","volume":"49","author":"Harada","year":"1990","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0068","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/b819896a","article-title":"Lessons learned from the contamination of heparin","volume":"26","author":"Liu","year":"2009","journal-title":"Nat Prod Rep"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0069","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc9993","article-title":"Heparin-induced thrombocytopenia in the ICU: an overview","volume":"15","author":"Sakr","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/ten.tec.2008.0060","article-title":"Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum","volume":"14","author":"Schallmoser","year":"2008","journal-title":"Tissue engineering. Part C, Methods"},{"issue":"9","key":"10.1016\/j.jcyt.2019.06.006_bib0071","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jcyt.2013.05.006","article-title":"Heparin concentration is critical for cell culture with human platelet lysate","volume":"15","author":"Hemeda","year":"2013","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.jcyt.2019.06.006_bib0072","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/CIRCRESAHA.112.265678","article-title":"Heparin Disrupts the CXCR4\/SDF-1 Axis and Impairs the Functional Capacity of Bone Marrow-Derived Mononuclear Cells Used for Cardiovascular Repair","volume":"111","author":"Seeger","year":"2012","journal-title":"Circulation research"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0073","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/jth.13312","article-title":"The design and synthesis of new synthetic low-molecular-weight heparins","volume":"14","author":"Chandarajoti","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0074","doi-asserted-by":"crossref","first-page":"305","DOI":"10.14573\/altex.2011.4.305","article-title":"Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media","volume":"28","author":"Rauch","year":"2011","journal-title":"Altex"},{"issue":"12","key":"10.1016\/j.jcyt.2019.06.006_bib0075","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1111\/trf.14324","article-title":"Comparative analyses of industrial-scale human platelet lysate preparations","volume":"57","author":"Pierce","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0076","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.transci.2009.07.005","article-title":"Platelet utilization in the developing world: Strategies to optimize platelet transfusion practices","volume":"41","author":"Verma","year":"2009","journal-title":"Transfus Apher Sci"},{"issue":"8","key":"10.1016\/j.jcyt.2019.06.006_bib0077","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1537-2995.2008.01718.x","article-title":"Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus","volume":"48","author":"Hourfar","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0078","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000358017","article-title":"Emerging Pathogens - How Safe is Blood?","volume":"41","author":"Schmidt","year":"2014","journal-title":"Transfus Med Hemoth"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0079","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/trf.14041","article-title":"First cases of Zika virus-infected US blood donors outside states with areas of active transmission","volume":"57","author":"Williamson","year":"2017","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0080","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/trf.14029","article-title":"First Zika-positive donations in the continental United States","volume":"57","author":"Galel","year":"2017","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0081","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bjh.12403","article-title":"Update on the use of pathogen-reduced human plasma and platelet concentrates","volume":"162","author":"Seltsam","year":"2013","journal-title":"British journal of haematology"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0082","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1537-2995.2009.02111.x","article-title":"Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La REunion","volume":"49","author":"Rasongles","year":"2009","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0083","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/vox.12376","article-title":"Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies","volume":"110","author":"Geisen","year":"2016","journal-title":"Vox sanguinis"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0084","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.transci.2014.12.016","article-title":"Development of blood transfusion product pathogen reduction treatments: A review of methods, current applications and demands","volume":"52","author":"Salunkhe","year":"2015","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4102\/ajlm.v5i1.363","article-title":"Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: A systematic review with regional discussion","volume":"5","author":"Nkohkwo","year":"2016","journal-title":"Afr J Lab Med"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0086","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000323845","article-title":"UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma","volume":"38","author":"Seltsam","year":"2011","journal-title":"Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0087","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1537-2995.2008.01691.x","article-title":"Solvent\/detergent treatment of platelet concentrates enhances the release of growth factors","volume":"48","author":"Burnouf","year":"2008","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.jcyt.2019.06.006_bib0088","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/trf.12068","article-title":"Virally inactivated human platelet concentrate lysate induces regulatory T cells and immunosuppressive effect in a murine asthma model","volume":"53","author":"Lee","year":"2013","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0089","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/trf.15205","article-title":"Viral inactivation of human platelet lysate by gamma irradiation preserves its optimal efficiency in the expansion of human bone marrow mesenchymal stromal cells","volume":"59","author":"Viau","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1423-0410.2012.01662.x","article-title":"Component pathogen inactivation: a critical review","volume":"104","author":"Prowse","year":"2013","journal-title":"Vox sanguinis"},{"issue":"7","key":"10.1016\/j.jcyt.2019.06.006_bib0091","doi-asserted-by":"crossref","first-page":"e0133070","DOI":"10.1371\/journal.pone.0133070","article-title":"Differential Expression Analysis by RNA-Seq Reveals Perturbations in the Platelet mRNA Transcriptome Triggered by Pathogen Reduction Systems","volume":"10","author":"Osman","year":"2015","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0092","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/09537104.2014.898178","article-title":"Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function","volume":"26","author":"Osman","year":"2015","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0093","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tmrv.2014.02.002","article-title":"Proteome Changes in Platelets After Pathogen Inactivation-An Interlaboratory Consensus","volume":"28","author":"Prudent","year":"2014","journal-title":"Transfus Med Rev"},{"issue":"8","key":"10.1016\/j.jcyt.2019.06.006_bib0094","doi-asserted-by":"crossref","first-page":"e0181406","DOI":"10.1371\/journal.pone.0181406","article-title":"Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells","volume":"12","author":"Viau","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.jcyt.2019.06.006_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1479-5876-12-28","article-title":"Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells","volume":"12","author":"Iudicone","year":"2014","journal-title":"Journal of translational medicine"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0096","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jcyt.2013.12.008","article-title":"Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions","volume":"16","author":"Castiglia","year":"2014","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0097","first-page":"315","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells","volume":"8","author":"Dominici","year":"2006","journal-title":"The International Society for Cellular Therapy position statement, Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0098","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365513.2018.1462082","article-title":"Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using bioreactors and human platelet lysate","volume":"78","author":"Haack-Sorensen","year":"2018","journal-title":"Scand J Clin Lab Inv"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0099","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/term.2377","article-title":"Clinical-scale expansion of adipose-derived stromal cells starting from stromal vascular fraction in a single-use bioreactor: proof of concept for autologous applications","volume":"12","author":"Gadelorge","year":"2018","journal-title":"Journal of tissue engineering and regenerative medicine"},{"issue":"11","key":"10.1016\/j.jcyt.2019.06.006_bib0100","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3727\/096368912X657990","article-title":"GMP-Compliant Isolation and Expansion of Bone Marrow-Derived MSCs in the Closed, Automated Device Quantum Cell Expansion System","volume":"22","author":"Rojewski","year":"2013","journal-title":"Cell transplantation"},{"issue":"12","key":"10.1016\/j.jcyt.2019.06.006_bib0101","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010071.pub2","article-title":"Platelet-rich therapies for musculoskeletal soft tissue injuries","author":"Moraes","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jcyt.2019.06.006_bib0102","doi-asserted-by":"crossref","first-page":"e1691","DOI":"10.1002\/term.2595","article-title":"Platelet lysate activates quiescent cell proliferation and reprogramming in human articular cartilage: Involvement of hypoxia inducible factor 1","volume":"12","author":"Nguyen","year":"2018","journal-title":"Journal of tissue engineering and regenerative medicine"},{"issue":"11-12","key":"10.1016\/j.jcyt.2019.06.006_bib0103","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1089\/ten.tea.2012.0225","article-title":"Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution","volume":"19","author":"Pereira","year":"2013","journal-title":"Tissue engineering. Part A"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00262-017-2055-2","article-title":"Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies","volume":"67","author":"Nowakowska","year":"2018","journal-title":"Cancer immunology, immunotherapy: CII"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jcyt.2017.01.005","article-title":"Human platelet lysate is a successful alternative serum supplement for propagation of monocyte-derived dendritic cells","volume":"19","author":"Svajger","year":"2017","journal-title":"Cytotherapy"},{"issue":"26","key":"10.1016\/j.jcyt.2019.06.006_bib0106","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1182\/blood-2008-09-181362","article-title":"Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo","volume":"113","author":"Reinisch","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2019.06.006_bib0107","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/trf.14541","article-title":"Manufacture of endothelial colony-forming progenitor cells from steady-state peripheral blood leukapheresis using pooled human platelet lysate","volume":"58","author":"Siegel","year":"2018","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.jcyt.2019.06.006_bib0108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129935","article-title":"Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity","volume":"10","author":"Tasev","year":"2015","journal-title":"PloS one"},{"issue":"9","key":"10.1016\/j.jcyt.2019.06.006_bib0109","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jcyt.2014.04.009","article-title":"Human platelet lysate is a feasible candidate to replace fetal calf serum as medium supplement for blood vascular and lymphatic endothelial cells","volume":"16","author":"Hofbauer","year":"2014","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2019.06.006_bib0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/term.2574","article-title":"Optimized human platelet lysate as novel basis for a serum-, xeno-, and additive-free corneal endothelial cell and tissue culture","volume":"12","author":"Thieme","year":"2018","journal-title":"Journal of tissue engineering and regenerative medicine"},{"issue":"37","key":"10.1016\/j.jcyt.2019.06.006_bib0111","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1016\/j.biomaterials.2013.08.018","article-title":"The effect of Platelet Lysate on osteoblast proliferation associated with a transient increase of the inflammatory response in bone regeneration","volume":"34","author":"Ruggiu","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jcyt.2019.06.006_bib0112","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3343\/alm.2014.34.1.43","article-title":"Effects of platelet lysate preparations on the proliferation of HaCaT cells","volume":"34","author":"Baik","year":"2014","journal-title":"Annals of laboratory medicine"},{"issue":"4","key":"10.1016\/j.jcyt.2019.06.006_bib0113","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10616-015-9878-5","article-title":"Culture of human cell lines by a pathogen-inactivated human platelet lysate","volume":"68","author":"Fazzina","year":"2016","journal-title":"Cytotechnology"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324919307893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324919307893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:40:25Z","timestamp":1761442825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324919307893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1465324919307893"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2019.06.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Professor Karen Bieback. Published by Elsevier Inc. on behalf of International Society for Cell and Gene Therapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}